Galectin Therapeutics | GALT - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Galectin Therapeutics

Galectin Therapeutics reported $-11527000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
AbbVie ABBV:US USD 5.08B 2.33B
Aceragen Inc IDRA:US USD -11055000 20.19M
Galectin Therapeutics GALT:US USD -11527000 893K
Immunic Inc. VTL:US USD -25272000 31.2M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Merck & Co MRK:US USD 4.48B 411M
Regulus Therapeutics RGLS:US USD -7139000 344K